Index of reports
> Life Threatening Events (8)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epogen (Epoetin Alfa) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Epogen side effects in 46 year old female
Reported by a physician from United States on 2012-07-04
Patient: 46 year old female
Reactions: Therapeutic Response Decreased, Refractory Anaemia, Bone Marrow Failure, Myelodysplastic Syndrome
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Epogen
Dosage: 20000 iu, 3 times/wk
Indication: Renal Failure Chronic
Start date: 2008-10-31
Epogen
Possible Epogen side effects in 46 year old female
Reported by a physician from United States on 2012-06-01
Patient: 46 year old female
Reactions: Therapeutic Response Decreased, Refractory Anaemia, Myelodysplastic Syndrome, Bone Marrow Failure
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Epogen
Possible Epogen side effects in 46 year old female
Reported by a physician from United States on 2012-05-30
Patient: 46 year old female
Reactions: Therapeutic Response Decreased, Refractory Anaemia, Bone Marrow Failure, Myelodysplastic Syndrome
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Epogen
Possible Epogen side effects in 46 year old female
Reported by a physician from United States on 2012-05-30
Patient: 46 year old female
Reactions: Therapeutic Response Decreased, Refractory Anaemia, Myelodysplastic Syndrome, Bone Marrow Failure
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Epogen
Possible Epogen side effects in 46 year old female
Reported by a physician from United States on 2012-05-14
Patient: 46 year old female
Reactions: Refractory Anaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Epogen
Possible Epogen side effects in 55 year old female
Reported by a physician from United States on 2012-03-08
Patient: 55 year old female
Reactions: Pulse Abnormal, Vomiting, Pruritus, Piloerection, Hypersensitivity, Dyspnoea, Nausea, Cardio-Respiratory Arrest, Chest Pain, Sneezing, Blood Pressure Abnormal
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Epogen
Dosage: 5500 iu, 3 times/wk
Indication: Renal Failure Chronic
Start date: 2012-01-21
Epogen
Dosage: 5500 iu, 3 times/wk
Start date: 2012-01-21
Epogen
Dosage: 4400 iu, 3 times/wk
Epogen
Dosage: 3300 iu, 3 times/wk
Start date: 2011-12-29
Possible Epogen side effects in 55 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-30
Patient: 55 year old female
Reactions: Pulse Abnormal, Vomiting, Dyspnoea, Piloerection, Hypersensitivity, Pruritus, Nausea, Cardio-Respiratory Arrest, Chest Pain, Sneezing, Blood Pressure Abnormal
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Epogen
Dosage: 5500 iu, 3 times/wk
Indication: Renal Failure Chronic
Start date: 2012-01-21
Epogen
Dosage: 3300 iu, 3 times/wk
Start date: 2011-12-29
Epogen
Dosage: 4400 iu, 3 times/wk
Epogen
Dosage: 5500 iu, 3 times/wk
Start date: 2012-01-21
Possible Epogen side effects in 54 year old female
Reported by a physician from United States on 2011-11-17
Patient: 54 year old female, weighing 69.4 kg (152.7 pounds)
Reactions: Pancytopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Interferon
Dosage: 96 mcg;qw;sc
Start date: 2010-06-16
Interferon
Dosage: 96 mcg;qw;sc
Start date: 2010-08-17
End date: 2010-10-16
Interferon
Dosage: 96 mcg;qw;sc
Start date: 2010-07-26
Boceprevir
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-08-17
End date: 2010-10-16
Boceprevir
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-06-16
Ribavirin
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-08-17
End date: 2010-10-16
Ribavirin
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-06-16
Epogen
Dosage: ;qw; sc
Indication: Anaemia
Start date: 2010-08-17
End date: 2010-10-16
Epogen
Dosage: ;qw; sc
Indication: Anaemia
Start date: 2010-06-16
Other drugs received by patient: Extra Strength Tylenol PM; Aveeno / 00302501 /; Tylenol (Caplet); Acetaminophen
|